Professional Documents
Culture Documents
Untitled
Untitled
42 weeks. The sacondry outcomes studied whch are relovant to [FG were length of gestion, maternal adverse ete, serous moro, mortality, and hemorrhage forthe mother, sillths, lw bit weight “or gestational age, and several compiations of prematurity for the one mores forte fans and se of heath sevice ‘observational studies inthe 19605 have reported longer pregnancy duration in {ish-enting communis Subsequent randomizee contol tial upported ‘his observation’ though tne get mechaism of action i stl unknown, resus of studs have stpported the suggestions that omega LOPUFAS ‘modulate prosalendn syhere and init plmitat-induceeinfamstory ‘cade, both of whien atin prolonging gestation RECOMMENDATION Supplementation with omoga-3 LCOUFAS significantly decrease te risk of preterm delvary at < 37 weeks and <34 weeks age of gestation (ACG) uot of uidence: Hoh ‘Strength of Recommendation: Strong 88 0‘The results were a shown blow: 3 Figure 2 Forest of riko preterm delivery 34 weeks with EShornefianet suolomentation with LCPUFA in efeent doses s20n in Figure 2, omega LCPUFAS aso significantly decreased the risk of rm delivery at fess than 3¢ weeks age of gastation (AOG) (RR 0.58, 955 C1 (0.77), Thebes results ware seen a doze: between SOO mg and 1/6 IRR, 1, 95% 1030, 0-75)" Figure 1. Forest pot of risk of preterm delivery <34 weeks wth supplementation with LCPUFAS in diferent dares ‘As seen in Figure 1, Omega-3 LCPUFAS significantly deceased the risk of prota dalvory st ess than 37 weeks (RRO 83, 95% C0. 80-097), ith tbat rests fr doses oF $00 mg to e/day (RR O.73, 985 C.6E-098)."" * omy Figure 3. Forest plot of rskof prolonged gestation with ‘supplementation with LCPUFAS diferent doses As Figure 3 shows, the Cochrane systematic review further conduded that supalomertation with omega-3 LCPUFAs didnot significantly proton gestation to> 2 weeks AG" Figure 4 Risk of perinatal death with supplementation with ‘omego3 CPUFAsin diferent dorer re shows that perinatal death wae aso not sgnifcanl affected by the omertaton with omega-3LCPUFAS.*sBaiiateadk Fivesstitanete Figure 5 Rsk of preterm delivery according to time fintation ‘of omega-3 LCPUFAS supplementation ‘QUESTION 2 tn preventing preterm bith, omega 3 LCPUFAS work best gen ¢ 20 weeks age of gestation uty of Evidence: High ‘Strength of Recommendation: Strong o JMMARY OF EVIDENCE 5 shsvates that in preverting preterm birt, omega-3 LCPUFAS work Ifthe are even < 20 weeks age of gestation (RRBs, 95% 10.76.95)" 2 ae Ea Se Figure 6 Forest pot of rik of prterm delivery <34 weeks according {time of tation of supplomentation af omega-3 LCPUFAE js, in preventing eary preterm delivery (¢ 24 weeks), they are best at 20 west (RRO, 95% Cl 0.43-0.75)™ a5 Figure shows,r] aak seas sent ssa sean Figure. Forest plot of isk of adverse maternal events wth ‘Supplementation of omege-3 LPUFAS Figure 7 states that omega'3 LCPUFAE were easly tolerated, Qerl there "Was Significant increase in postpartum hemorrhage (AR. .03, 95% C1 0.82 £130), severe matemal adverse events (RE 1.08, 95% Cl 042.72) or in events ‘severe enough to cause cessation ofthe medication (RR L.01. 95% C1052 1.93) sithough there were increased complains of voriting,beching or burp.” ‘From this meteanayss, t_may be concluded thot omega LCPUFA supplementation, started eatin pregnancy, at dose of S00 mgt 28/y, ‘etve in proventing preterm Isbor ana delivery wth Mle or no sigifeart rivers oferts and with late low cost tthe mother. 98 uh he Cochrane reviewers di not recommen further studies comparing 13-3 LCPUFAS supplementation and plaabo in reverting preter sbor ‘elvery, they propores that further tudes be conducted onthe effect of 4-3 LCPUFA supplementation on growth ana development and longer outcomes forthe mother ae child” Lip ct utnr 857h t of3 PUFA plone on oe ater Iolanesten nt gacrn ana mater Some sng reemrey Foner a en ny aes 26 13859 nin €7 Gon Phew A Mie Mh fog in ahead ten Somat 1 da ret a Ong oy acl bin Ao ene, ean oat 20 3:02chon 10 Sgt (13% ma 1h 075, 95% 1058-098 hte thre was no Sant iferece between the two reps In te wos nanber of Cervical Cerclage riage, stilbene and deaths following live births, suberoup analyses for Prevention of Preterm Birth yealed that women with a history of 3 more pregnancies. ending before 37 Gs ncttad rom ora tts delvery bere 23 west Geese by ate Catelen Senge, MO, FPOG,FSUDG, Far iin the erclge soup (55.32% P eS) let was sen nose DEFINITION oF TERMS ‘+ PRETERM BIRTH ith between 20and 36 6/7 weeks” SHORT CERVIX ~coricsllorgth of es than 25 mm, messured at the mid ‘master, a tansvaginal or vanslbalubrasouna! 1+ CERCLAGE ~ a procurein neh sutures are uted te dose the crv dune pregnancy to prover pregnancy loss or preter bith, The approach may be ‘eansagial,ransabdorinal or laparoscope ‘+ MsTORYANDICATED CERCLAGE ~cercace performed because of woman's increased rik for preterm delivery secondary ta her obstetric oc eynecloek isang ‘+ ULTRASOUND INDICATED CERCLAGE—cerage performed in asymptomatic women, where the ceric is seen te Be shortaned Ia. tanwagial Strasouna™ 4 RESCUE CERCLAGE ~cercago performed as an emergency measure in cases ‘of ceri latation with exposed fetal membranes ater dbeovery through uitrasound of pelvic examination” Cerlage ry be offered to pregnant women oth history of spontaneous second trimester losses or preterm bir, wo, on transvaginal ultrasound Survellanee were found to have erica length oF 2S mm oles before 24 wee of gestation. Ie ismot recommended in women: 1. Without 2 history of spontaneous preterm delvory or mid-rimester loss who Rave an Incidental fining of a short carviz on uraiound 2 With uneling of the cowie where the cervical lengths 25 mm or longer ue of Evidence: Hoh ‘Swenat of Recommendotion: Strong RECOMMENDATION Histoyindeated corte may be offered to women JMRAARY OF EVIDENCE ‘th history of 3 or more preveus preterm deliveries and or second vimeste losses, net al, in randomized controle ral and Berghe al "ina mets rll, both found that these with history of preterm bits and wid-rimester plus acerca length atc less than 25 mon sonographic survellance st before 24 weeks, benefited trom carlage compared to those Weated wit ectant management (RR 0.57; 95% C1 033-099 and AR 0.62; 95% CO. ‘unity of Evidence: Hi Srength of Recommendation: Song SUMMARY OF EVIDENCE Three randomized contol trials (ACT) compared the outcome of history: J To. a! measured the caval length of 47,123 woren with rik actos for Indicated cercage against expectant management. Thro wers fewer deliveries ri birth at 22-24 weeks AOG. Fourhunded seventy (470) women wa before 33 weeks inthe ceriage group matched up agsinst those with no eto have a cervix measuring 1.5 cm or less, Fy four percent (55) of 00 101‘those women agreed tobe randomized to ether the performance of a earcage ‘of expectant management. There was no signfiant ference the ieidense preterm bith In the cerdage versus expectant management group (22% vers 268). There sno ovealeidence of benef for crlage in worn with a shartened eric with no ether rFactor: RECOMMENDATION The choice to place a rescue cerdaze should be Indlualed since the risks of preterm delivery and ‘neonatal mortal are high. Advarces distton ofthe ‘cervix of 4 cm or move cr prolapse ofthe membrane beyond the eternal ceria os fe associated ith 2 igh incidence of cercage allure Quo of Evidence: oderate Stergth of Recommendoion: Weak SUMMARY OF EVIDENCE ‘Theres only one RCT comparing rescue crclage and bed ret sone. Althusis tal. stated 23 women who were seen to have ollatedeavics and prolapsed Imambranes. at 3 mean gestation of 22-23 weeks All of them were hospital and on ad rest uni 30 wees of gertalon Those allocated to the ‘cetage group were ven preoperative indomethacin, Those inthe cerdlage sroupdelveres on average 4 weeks later tan thos inthe bed ext group an» Elgitican eduction in delivery before 34 weeks (59% vs, 100%, PeD93). There was no deta provided on the incidence of chorlumniontis or neonatal ‘more. 102 ]ONd When iscercageconaindetest IENDATION The performance of 3 cenical cerdage is not rezommended inthe following cumstances + Actve preterm labor Evidence of ovtoarriontis Continuous vaginal bleeding Preterm prelabor ruptureof membranes {Evidence of etal cmpromize Lethal fetal congenital defect Fetal demise" uot of Evidence: tow ‘Stengthof Recommendetion Weak /GPP ethan vot a veal seamen by uaa for pig Peter din {Rene The Ccronecolaarton 2082 ance agua er opi proven cel ec the prerion of eee arn wre wh ong hoe ere, prev pres th an pet "fst sytenseetaanas dine cemanean meena te ra ‘fobsmasandGyeany, 201 iy 28k ca vee, 2 Ciel te etl fr peeing pret ln regan, Gxraneosoestnste ia 20288 oo reen Ton encine ocr ay 208 tan Gepon 5 Deo eal Muicered cnt i of xe coins Eta 5 tal Avena rte kt eral cogs woman 298 rsp tem deny Oot perl ne 79880 Fl vpo of the Model fseah cau? ol Clkgr of Obeies and Gnaogss tara arco lf eta ee, MMIDG Harn ary ncevealsdage Oh Oya 199 056-9 ‘ven Hale erp Wet eid fea ar presi rn revo fh wien mi stares i net es ag mdb Gee 288 20375028 Berea, Ode 80, To Sst OA, Ae SM Cerne fo sho ce on [Mbeeearone: metre fel ng tba pene en, Oras el40. To mS AME 2 Hen NE Cet Ft Meena Sc Teer Scene Gn, aul arcs o mevern ot pete day wah eh sero anamzed coal ne 2008 389553 ‘tha 2 altar ual en lH, Cade compan prevanon Yanda crag st ery cre th nd tet vrs bd os lor rete 20 180730, 104 afore |. Sates, MD, FPOGS, FPSUOG, FPSM>M Use of pessaries near reports was for the prevention of spontaneous tern birth that useé modal thet were ocgeally intended to treat genital p50 Closet a. descibes hie experianee sing 3 rng pear in 13 patios lier 2 story of crea lacerations, eval ineomaetence of uterus phys, as ted by Oheran and dei 3968, Vrsky described the use of a Hodge pesaryin sven patients and in 8 patients from colleagues. He postulated that the redution of peste on = Internal os prevented the protresion of membranes.2® He sso suggested the pessary might change the inesnation of the cereal canal to id In cessing the ceri but ths was never proven, and considoing the lrge ngs of he Hodge snd ng pesraries, this oe Not seen tobe hey. Ones ver! aso used Hooge essary in 29 patients with “crveal srpetence, guns that treatment with 8 pessary would be supener 0 jl erage since reduces the kof leedng or maternal sepsis, Inter pessaies that were designed soeiclly for pregnant women ated mainly from East European counties. ato eta desea + faye ring passa” which ic made of organic aes” Jerde and Hamann ‘Germany developed s pessory that was supposed to sutound the ning cervix witha a butterli-shiped design that had lager eameter rs te saetum and asmaler diameter towards the symm the ate 19705, Hans rain of West Germany devised a round cone-shaped ry that Is made of fenblesilone. Its dome: tke design resembled the nal omic that eed to surround the car a8 close ae posible to the al 05! The design had the intention of not only supporting. an pressing, But se Icing the cervix ane pony rotating i mre towards 105RECOMMENDATION ‘The use of caval pessary for the prevention of preterm br in women with 2 sonogeaphicaly shor. fcevie maybe benefidal in certain populations. Further studies are needed to validate Is potential benefits as curentstudles show inconsstent resus, uot of Evidence: iow ‘Stengthaf Recommendation: Weak SUMMARY OF EVIDENCE “he fist mulieenter randomized contclled wal (RCXY" on the use of the peseacy included 385 unselected wornen who were screened by transvaginal ‘resound (TWUS) The sty showed tatin woman wth short cerca ength (25 mm between 18 and 22 weoks age of gestation (AOG), the pessary brolonged she pregrancy and edaced the rte of poor outcome compared with font. The women wore randomized to receive petty (S192) of expectant management (913) Inthe pessary group, there were fewer bts before 3¢ weeks (3 versus 27% RA. 024; $55 C10.13-043, before 37 wees (27% vers 59%; RR 0.36; 95% C1 0.27-0.49) and before 28 west (2% vereut 3% RR 98% Cl 0.09-0.73), showing a signifi ference inthe occurence ot composite poor neonatal outcome 2 smaller RCT that involved 108 Asian wornen with snleton pregnancy an» ‘cerca lerath 25 mmr routine second trimester transvaginal san showed 2 Sima trend favoring the Use af cecal pessary. The mean gestatonal age st alvery wat 38.1 wees inthe pessry group compared wih 37.8 wets inthe fexoecant group, wth ne significant aferences inte rates of delivery afore 28, 34037 ach | single-center parallel group RCT by Saecon tal" included 300 women wth ‘zymptomatie pregnancies and without prior spontaneous preterm Hh but ‘th shore card! length [-20 mm) on ansvaghalulvascund. The subjects ‘were randomized to Yeceve 2 cereal pessary (intervention group} or no Desrary (contol group). Women In both groups were prescribed vagina ‘progesterone 200 g supposes daly ntl 36 weeks and dys of gestation. No recommendation ia rade about ted es, att) or vagina inereoures 106 7 primary outcome was spontaneous preterm bith at ss than 34 weeks of on. The results showed that spontaneous preterm birth 2t<34 weeks red in 11 women 7 3 nthe pssay group and 23 women (15.3%) nthe rl group (between-group eillerece, 8.0%: SSK C157 to 0.4%). The therefore concluded that smong women without pror spontaneous feterm bith who hod. ssymetomatic singleton pregnancies end. short vaginal cereal length, cricalpassary use rested In a lower rate of neque preterm bin at < 34 weece of gesabOn, sacondary outcome measure in Saccone's study also favor the ute of eal essary a was asodated with lower rate af spontaneous preterm ‘at <37 weeks gestation, a longer gestational age at delivery and latency ancomizationt delivery, higher bith weight, ower rates of admision to ‘neonatal intensive care unit (NICU) and a lower Incidence of adverse natal outcome compared to group thathad no pessary. ny nthe systematic review and mets-anayss conduc by Seccone alin 20179 aire 3 RCT (= 1420) wore included, cervalpessary use dd duce the rate of spontaneous preterm delivery or Improve perineta 3c. However, Incvcual patient date mets analy may nate whether | pesary could be Benfl in cartaln subgroups of women angeton nes without prior Nstory of spontanzous peter birth but have short rvces on transvaginal ultesound), rulicanter RCT conducted in 2026 by Nicelide a a, ako supported Aine thatthe use of ceva pssary showed no sigliieant ference In rate of spontaneous delvery before 34 weeks, perinatal death, adverse outcome or neonstl speci care compared withthe contre group “The use of cervical pessary in twin pregnancies with shor cereal length on transvaginal Ustasound at 126-24 weeks i not recommends because It does not prevent spontaneous preterm birth or improve perinatal outcome. uct of Evidence: High Suength of Recommendetion: Strong 107‘SUMMARY OF EVIDENCE In 2017, « meta-analysis evaluated the effectveness of conical penser for preventing spontansoue preterm beth (SPTB) vn twin pregnancies with an symptomatic transvaginal ultrasound earvl length (TVU CL) in the second ‘eimester. Three RCTs that included 482 twin pregnaeles with sonogrephiclly ‘hor cervixin th second waster 26-22 weeks) camped the use of ervet ‘estar with expectant management. Two RCTs used VU CLs 25 mm andone ‘see TWU CL 38 mm 35 cutoff. the meta-analysis concluded that dhe use ef ‘ceric pesary was nt sssecated with preverton of spontaneous preter bith, ane tha mesn gestational age at delivery an the mead latency wer sirlar in the pessary group compared to the contol group. Simi, no benefits were noticen the neonatal outcomesin the pessry group. ‘Thangtorai etal” conducted arather systematic review and mete analysis in 2018 to ases the electvenes of cerscalpessary inthe prevention of preter births They were ikewisa unable to show benefit of uring erie! peteary i twin eegrances with short cons ‘questions: ‘Should women receive supplemental vaginal progesterone afer cerclpessry insertion? RECOMMENDATION Vesna progesterone may be given to woman after cervical pessar insertion to lower the rate of preterm deivery ‘elt of Evidence: Weok ‘Svengt of Recommendation: Strong SUMMARY OF EVIDENCE In a retrorpective cohort study af 202 women with slogeton pragnancc: managed in to tertiary medical centers, one canter used 2 combination ct ‘ere pessory ang supplemental vagal progesterone (study group) and the Second ed oniywebnal rogesterene. in worn who had 9 short can 07 ‘TWUs done between 18 ad 29 weeks gestation (corto grup). Ninety fur (34 ‘F465 women were incuded in the study group and 108 (S3%} waren were indus inthe conte group. he study showal that the cmblned treatment of cervical pesary and vagina peserone had a lower rte of preterm delivery <34 weeks of gestation and abl to prolonged gestation when compired to those women who were ted wth only vaginal progesterone; Nowover, mare randomized control fs ee ned to validate these resulta Prato 3933838, (ny mes etme of te nett candle. at Gye 19631732 {hy N.The compet ena sand the pe A Ca yal SG P44 (= ve rnin fh nampa cov wih the Hobe psy. Obet Epc ss 205308 Int un ats fuse enmert ef reccous ery. Contin ft {needy eg: tone pay Cskaal TULA “Sra chown cron ng spre peste Peon an eae ot rath sol atl oP 09386635. Eien rrerooc (ent wh pvr gegen ih Tiss ‘Serean oY 81208278, cr ra a ce pn pat one o 2 ast or CM, Lau Tao TT Lung ¥-Ceelage psa fr prevent peer thin ivr astain Sarna ee ot 8 m3 mand Sine ttn © Shake & Min ec of Cn en on xSomeac em rin Warn aha Mewes rd Shr Covel eg aoe sr iss ae ‘Scare crs cota Caren psy et prvering pret rn pen Seip tetaaeies s amenae cw sanco ssn) Oe fea irae 2880. free were aston th MEnl Mad 936 943010052 Src crt ew ap clon erga ith Inimitle ep win nr cr SPA composted mea Sat Maeno Necea es 04,382) Ia owe en etal Sonal ey whine Jouce/irensa seaasT08 109Chapa 12 Calcium Channel Blockers (Gumesnda Cuz-Jver, MD, FPOGS,FPSWFM, FPSUOG ‘aa Konsuelo , Cha, MD, FPOGS lium channel blocker sone ofthe most commonly uted tools tacts by reducing smooth muscle contacity by decreasing the ff of ealeur into ‘els. iene, which hasbeen widely use in the treatment of hypertension, has been exensvely died in the management and contol of preterm ler ‘Talimprove neonatal oucomor, it ic racommended that women with imminent preterm lator receive tocol therapy and antenatal cortinsterads and ‘elverina tert come. The goal of iil tools iso delay dalery For at leost 48 hour, allowing completion of couree of crtiostrois fr feta uns ‘maturation and maternal trarfer to a tertiary center with capale neonatal fntesive are unt (NICU) fies * ‘QUESTION 1 ‘Which tocovtic agent is mast eflacive at delaying ‘elvery for 48 hours to allow the adehnsration of antenatal corcosterolds? RECOMMENDATIONS fedpine hod the highest probability of delaying doivery by 48 hours, Improving neonatal outcomes nd with relathely tow materal side effects and therefore ti racommended for proce uty of Evidence: High Seng of Recommendation: Song SUMMARY OF EVIDENCE “ne work of Hass and clsgus utes network meta-analysis methodslogy forthe steeemont of different tocol therapies. This is the fst of sein coiteres because It alws dest and indirect comparisons ot toolyte {Testes among ifaent trials, ft was concluded tha provtaplandin inhibitors land calcu chanel bicckrs had tho highest probably of delaying deliver by ‘42 houre and improving neonatal outcomes and with vlativey low eacern’ ‘Sdeeffecs. 10 Fostananain inhibitors, magnesium sulfate, calduen channel blockers. B matics and atoslan were the toclvies included nthe analysis. When pared with olsesa, prostaglandin inhibitors had the Nghastprobeblity oF fbjing deiery by 48 hous (OR 5.39, 5% 1 214-1224), There was no syde that was signfeanty superior to placebo In reducing neonatal pratorydstess syrome er neonatal morality. Compared with ploebe, Tocolyics that has the hehest maternal adverse elects were mimetics 2.68 95% 0 7.51-73.67) and magnesium suifate (OR 8.15, 958 cl 247 70), Prostgandin inhibitors and calcium channel bleckers were ranked In top tree medestion clases for maternal and fetal outcomes and side Ee iON ‘Among pregnant women with preterm labor how ‘effective nifedipine In improving perinatal. ‘outcomes compare to other tools? IMENDATIONS Nifedipine is superior to. Pr2-adrenestreceptor agonists and magnesiur sullate for tocol in women with preterm labor and can be ued 35 the gent first cole for toch uit of idence gh Strength of Recommendation: Strong IARY OF EVIDENCE systematic review and metaanalsls conducted by Conde-Agudeo et a. in 21 evaluated the resuts of twenty-sx randomized conlled trai that yded 2179 women. The rasuts showed thet rHesipine was associated witha enficant reduction In the risk of delvery within 7 cays of the onset of nent and belore 34 weeks! gestation compared with B-2-adrenergc- 10 agonists. It aso has sigaicanty fewar maternal adverse events onatal averse cutcomes such 35 respiratory distress syndrome, necotin ercoli, nraventiular hemerthage, neonatal janice, and admission tO NICU were ato reduced Comparing magnesium su'steon nifesiping, bot ‘shown to ve the some toalyticeffcay. As a maatenance 2a, pine was not effete In prolonging gestation or improving neonetl cs when compored with ne tress mTable 1 shows that sfeipine was asocated wth a sgnfeant increase in pregnancy prolongation compared with magnesium sulfate, atasban, ad nivic ‘ne donors. “ABLE. ACUTE 1OCOLYSS:NFEDIPNE COMPARED WITH MAGNESIUM SULFATE, ATOSIAN, AND METRIC ONDE DONORS ww a7 Ee ams Saami 2 Ram ‘sarcnarepnt re SoscER tenant a raeemnpceapc 2 IMENDATION The effect of nifedipine in prolonging pregnancy is sual to the oflec of ther treatments (placebo, ‘Progesterone o atosban) and its use for one-term tocolsis isnot assodated wth improved perinatal ‘euteome; therefore I should not be recommondd ‘or routine practice fr this purpose uct of Evidence: gh “Serength of Recommendation: Strong JMMARY OF EVIDENCE als for Pregnancy Prolongation Below are the resus of 2 metaanaisis of ten journal ates that usted the effect of rfedipne on pregnancy prolongation As observed from "study of Pir, the longest pregnaney prolongntion among thor teates rifeipine estiated at 468 days with an estimated mean diference equ 0 dave, Half of te stuces Favor riesipine in rotonging pregnaney mean ce, MD>O], Among these 10 stuces, the highest contribution to pacled ‘iernea came from the study of valet in 2015! while te lowest luton came from the study of Pany ublsted in 2014. high percertage ) of the total valation among estimates can be attibuted to the nety of the suciee rather than chanes, On the average, the mean ‘estimates vary rom the true effect siz by as muchas 36.68 (Tu), measures imply tat ties included nthe alysis Yay in pasty many ete uch ae sampling vartion and elillrencs of the targat population. ely, hevarozenity test found that vation in mean ference was (toe signa, leading the conclusion cat he stdles included wore a, the mean premnancy prolongation amorg sifcipine weated women 26.01 days (Table 2, This wn lower than the mean pregnancy prlorgaion 2754 days obcerved ariang women wha were aven other veatman's. The Jed mean sliference was estimated to be “153, indicating tat the fancy prolongation in women tweated with awas lower than the pregnancy ration In control women. Howave, this poled men difernco wes not 3stately sgnifant f-alue-0.485),impyng thatthe effect of epi to long pregnancy was equal to the eet of ther treatments such placebo, broverteroneoratosban Table 3). “ASLE2: AVERAGE PREGHANCY PROLONGATION AB1£ 3 PooUrD MEAN DFFERENCE “The forest plot in Figur 1 istretes the affect sine of nifedhine compared to coer treatrents. teary shows thar stele ae dided in suggest Which trestment arm worked better. can be seen from the plot thatthe estimat= from the study of Roos sth closes othe etinatd tras fect sie (poste) 'Mo) and te estimate is aso precise, Hence, high weight was assigned to this study (22.42%). Pregnancy Prolongation FIGURE FOREST PLOT OF PREGNANCY PROLONGATION. the study of van Vit eta entitled “Mediine Maintenance Tocohsis ane tal Outcome: An Individual Paripent. Data Meta-Analysis si rized controlled tals (RCT) encompassing 787 patients (n=390 for pine; n=397 fr plaebo(no treatment were evaluated. The meta-analysis uses (at maintenance tocolysis Is not associated with Improved natal outcome and is therefor nt recommended for outing practice. 2 sud further notes that there was no ference between the groups in i ofthe incidence of pernatl death (sk rato, @R 1.38, 95% confidence |, 95% C1 035-533}, traventiclar haemorrhage (WH) 2 grade HR 5 95% C1 0.16-2.67), necting enterocolts (NEC [AR 1.13; 95% C1 0.80 infant respiratory distress syndrome (ROS) (RR 036; 85% Cl .1-1.85), i prolongation of prepnancy (hazard ratio, MR O74; 85% C1 0.55-1.01)") all the affect of nifedipine on the rsk of neonatal deeth (Table 4), ratory dstress syndrome Table 5) itraventriular hemorhage (Table 6) necrotizing ontrocolt (Table 7) equol othe effect of other treatment hae placebo progesterone or atosiban based on the peced cds atc (03) ‘the meta analysis of RCTs by Cand, vant" Tan" Songthmwat eisai 5ABLE 8. META.AUALYSS FOR NEONATAL DEATH "TABLES. META. NALS FOR INFANT RESPHATORY DISTRESS SNOROME Seyeaenie | To 16 {COMMENDATION The comrinaton of 1} sional cate with rifeipine and 2) Indomethacin. with ifecpine oper to be superior in the management of ‘Greatened preterm labor compared either ofthe Imedietont especialy nfedpine aloe. The ‘ombination may rerefore ba used in practice. uolty of idence: Moderate Svength of Recommendetion: Strong OF EVIDENCE the 2014 Cochrane Database Syetematc Review done by Vogtle ented bination of Tocclytc. Agents for inhbing Preterm Labour" was fomed tha" remain unclear whether using 2 combination of tocolte for inhibiting peste nbour is more advantageous for women and/or orm gen the lack of tis" Therocos use nthe various stules were evaluated ints teview were Betaimais oF magnesium slate nation with indomethacin, vaginal progesterone, hexoprenaine suet, lol and penton One study even used fenoterel plus oral rose. Nove ofthe stiles ures the mote popular toate agents such 25, lam chanel Blockers fesipine) nd indomethacin, 7